REVOLADE

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug REVOLADE contains one active pharmaceutical ingredient (API):

1 Eltrombopag UNII 4U07F515LG - ELTROMBOPAG OLAMINE

Endogenous thrombopoietin (TPO) is the main cytokine involved in regulation of megakaryopoiesis and platelet production, and is the endogenous ligand for the TPO-R. Eltrombopag interacts with the transmembrane domain of the human TPO-R and initiates signalling cascades similar but not identical to that of endogenous thrombopoietin (TPO), inducing proliferation and differentiation from bone marrow progenitor cells. Read about Eltrombopag

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
Revolade	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC
REVOLADE Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B02BX05	Eltrombopag	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BX Other systemic hemostatics
Discover more medicines within B02BX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 5825N, 5826P, 5827Q, 5828R
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 526517050089317, 526517050089417
Country: CA	Health Products and Food Branch	Identifier(s): 02361825, 02361833
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 2671-MEE-0417, 3035-MEE-0917
Country: EE	Ravimiamet	Identifier(s): 1461990, 1462003, 1462014, 1462025, 1462036, 1462047, 1696158, 1696169, 1696170, 1715396, 1715408, 1715419, 1715442
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 10612002, 10612005, 110612013
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 048177, 048189, 428609, 494314
Country: FR	Base de données publique des médicaments	Identifier(s): 60757264, 61736230, 61951699, 67675236
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 170753, 170756, 347006, 394262
Country: HK	Department of Health Drug Office	Identifier(s): 62055, 62056
Country: IE	Health Products Regulatory Authority	Identifier(s): 88313, 88314
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6326, 6328
Country: IT	Agenzia del Farmaco	Identifier(s): 039827011, 039827023, 039827035, 039827047, 039827050, 039827062, 039827074, 039827086, 039827098, 039827100, 039827112, 039827124, 039827136
Country: JP	医薬品医療機器総合機構	Identifier(s): 3999028F1025, 3999028F2021
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1053805, 1053806, 1053807, 1053808, 1053809, 1053810, 1072070, 1072071, 1072072, 1080020, 1080021, 1080022, 1080023
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 108219, 93963, 93971
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 14582, 14583, 16164
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100219971, 100219988, 100245141, 100369908, 100369914
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64445001, W64445002, W64445003, W64446001, W64446002, W64446003
Country: SG	Health Sciences Authority	Identifier(s): 13909P, 13910P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 20833051H, 80833052H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699504092103, 8699504092110, 8699504093087
Country: ZA	Health Products Regulatory Authority	Identifier(s): 44/26/0548, 44/26/0549